Abstract
S5).
We sought to prioritise these indels for further investigation by considering their 3 3 2 potential impact on transcription factor binding. We ranked indels which lay within 3 3 3 transcription factor binding sites, using chromatin immunoprecipitation (ChIP-seq) data and (32). The two windows which we found to be the most highly transcription factor-occupied transcription factor ChIP-seq annotations; n = 4 indels) and chr12: 107,380,956-107,380,983 3 3 8 (indels overlapping a maximum of 46 transcription factor ChIP-seq annotations; n = 3 3 3 9 indels). The former region on chromosome 15 lies within the first exon of B2M, and the 3 4 0 variants found in our cohort disrupt a repetitive ' CTCTCTCTT' motif within a protein- previously been described to our knowledge, and we validated all three indels via Sanger sequencing (Fig S5a) . The region lies within a putative promoter for the mitochondrial 3 4 6 transcription termination factor (mTERF) MTERFD3 (Fig 5c) . The indels in our cohort MAZ (Fig S5b) . Further analysis is limited by the fact that we do not have sample-specific 3 4 9 transcriptomic or epigenomic datasets available for each sample in our cohort. However, via RNA sequencing, as well as SP1 ChIP-seq reads overlapping these indel loci (Fig S5b) . We also observed E2F6 and MAZ ChIP-seq reads overlapping these indel loci in the HeLa mitochondrial DNA (mtDNA) copy number depletion (34) and mtDNA copy number variation has been observed in cancer tissues (35) . However, experimental functional 3 5 7 validation will be required to determine whether these indels might contribute toward 3 5 8 oncogenesis through such a capacity. non-coding driver mutations may have arisen due to current studies being underpowered to 3 6 3 pinpoint drivers present at low to moderate frequencies (5-7). We undertook this study in part to determine whether TCS may enable researchers to increase cohort sizes when seeking to 3 6 5 identify driver mutations in defined regions of the genome. We performed WGS at ~60X 3 6 6 coverage genome-wide, requiring approximately 900 million 100 bp paired-end reads. Our regions. Therefore, TCS could potentially boost sample sizes by almost 30 fold, whilst also 3 7 0 increasing sequencing depth by three fold. By increasing sequencing depth, we identified 3 7 1 51% (n = 2,457) and 144% (n = 39) more single nucleotide variants and indels, respectively. Therefore, we find TCS to be a sequencing-efficient method to answer specific research questions in large cohorts. Despite the benefits of TCS that we have demonstrated however, certain limitations upon downstream analyses should be noted from this approach. For example, while we were able to associate CRC_4 and CRC_3 with deleterious germline variants in MSH6 and MUTYH respectively, we were unable to fully investigate the underlying cause of the high 3 7 8 mutation load in MSS sample CRC_16, nor the associations that we observed between the 3 7 9
additional MSS samples in our cohort and signature 18. The causes of these distinct mutation sequenced were selected using only a single colorectal cancer cell line. A number of factors can impact the determination of the driver status of a non-coding 3 9 1 mutation. For example, there are a plethora of ways in which a non-coding mutation may site, affect the partitioning of the genome into topologically-associating domains, or cause chromatin organisation or CpG methylation (1). In this study, we have proposed a list of 3 9 6 single nucleotide variants and genomic windows containing recurrent indels, which may be 3 9 7 functional mutations in the non-coding genome. We did so by using measures of recurrence,
FunSeq2 score (29), and annotations of transcription factor binding. It is possible that others of the recurrent mutations that we identified are actually cancer drivers that impact the 4 0 0 genome in a way that is not captured by these analytical methods. It is also possible that 4 0 1 many of the mutations that we have selected as potentially functional are actually passenger 4 0 2 mutations, and therefore do not act as drivers in colorectal cancer. In our study, we did not 4 0 3 find any strong candidate regulatory driver mutations, and so we did not perform any further methylation, and regulatory elements such as these are generally lowly methylated (40). Taken together, our study has demonstrated TCS to be a sequencing-efficient 4 2 6 alternative to traditional WGS analyses when seeking to identify variants at specific loci 4 2 7 among larger cohorts. We found that the increased sequencing depth afforded by TCS allows suggesting that with our current sample size, such mutations may be rare. A unique TCS assay was designed to provide sequencing data covering regulatory Table S1a ). Promoter elements were selected to primarily include the 4 3 9 region ±450 bp of FANTOM5 p1 promoters of canonical genes (9). DHS sites were selected biobank, and were unbiased for gender, cancer stage or tumour location ( Table 1, Table S2 ). Hospital, Sydney (ethics numbers H00/022 and 00113). Samples were sequenced using our were processed as previously described (39) (see Table S3 for sample names). MSI was 4 6 9 designated if the sample was listed as being MSI high (MSI-H) via annotations from TCGA. Germline variants were detected using the GATK pipeline (44), and were visualised 4 7 2 in figures using the Integrative Genomics Viewer (IGV) (45, 46) with the BAM files BAM files were additionally filtered to exclude reads which mapped to multiple loci by variants were detected with Strelka (10), using the bwa configuration file and default incorporating the VAFs of somatic mutations was created in R using ggplot2 (47). Somatic 4 8 1 indels were detected using Strelka (10) with parameters as described above, as well as
SvABA (17) and Lancet (18) with default parameters. Segments of assembled chromosomes 4 8 3 which had high sequence homology with unplaced scaffolds of hg19 were identified using were normalised against those from the COSMIC database using genome trinucleotide Pearson's correlations reported had P < 0.0001, indicating a correlation coefficient that is 4 9 3 significantly different from zero. error-prone and are typically repaired by the mismatch repair process that becomes deficient in MSI tumours. The mononucleotide markers used were Bat25, Bat26, Bat40 and Cat25, as 4 9 7 described previously (11). POLE exonuclease domain mutant cancers were identified through RNA-seq -Ribonucleic acid sequencing References 5 8 3 *TCS cohort is the target capture sequencing cohort described in this publication, containing 95 colorectal cancer samples. TCGA cohort is The Cancer Genome Atlas cohort containing 46 whole-genome sequenced colon cancer samples (Table S3) . ^ This is the "Non-Coding Score" provided by FunSeq2 (29) via a weighted scoring scheme, where higher values indicate variants that may be more likely to be noncoding drivers. MSI = microsatellite instability. GERP = Genomic Evolutionary Rate Profiling (GERP), a measure of conservation where higher numbers indicate more conserved sites. ENCODE = Encyclopedia of DNA Elements. TFP = transcription factor binding peak; TFM = transcription factor bound motifs in peak region; DHS = DNase I hypersensitive site. 
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